Product NDC: | 0641-6113 |
Proprietary Name: | Adenosine |
Non Proprietary Name: | Adenosine |
Active Ingredient(s): | 3 mg/mL & nbsp; Adenosine |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0641-6113 |
Labeler Name: | West-ward Pharmaceutical Corp. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA076500 |
Marketing Category: | ANDA |
Start Marketing Date: | 20040616 |
Package NDC: | 0641-6113-10 |
Package Description: | 10 VIAL in 1 CARTON (0641-6113-10) > 2 mL in 1 VIAL (0641-6113-01) |
NDC Code | 0641-6113-10 |
Proprietary Name | Adenosine |
Package Description | 10 VIAL in 1 CARTON (0641-6113-10) > 2 mL in 1 VIAL (0641-6113-01) |
Product NDC | 0641-6113 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Adenosine |
Dosage Form Name | INJECTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20040616 |
Marketing Category Name | ANDA |
Labeler Name | West-ward Pharmaceutical Corp. |
Substance Name | ADENOSINE |
Strength Number | 3 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Adenosine Receptor Agonist [EPC],Adenosine Receptor Agonists [MoA] |